Simultaneous Treatment with Statins and Aspirin Reduces the Risk of Prostate Cancer Detection and Tumorigenic Properties in Prostate Cancer Cell Lines

Table 2

Distribution of patients according to the diagnosis of PCa and HGPCa and the treatment with statins, aspirin, and the combination of both treatments.

	PCa detection (%)	value	HGPCa detection (%)	value
Nontreated cells	552/1504 (37)	—	136/552 (24.6)	—
Statins	152/440 (34.5)	0.879	40/152 (26.3)	0.673
Aspirin	64/160 (40)	0.536	24/64 (37.5)	0.034
Statins + aspirin	80/304 (26.3)	0.003	40/80 (50)	<0.001